6955 logo

Bonraybio TWSE:6955 Stock Report

Last Price

NT$141.00

Market Cap

NT$2.8b

7D

-0.4%

1Y

90.1%

Updated

12 Dec, 2024

Data

Company Financials

6955 Stock Overview

A development stage company, manufactures medical instruments and solutions for the male infertility market. More details

6955 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Bonraybio Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Bonraybio
Historical stock prices
Current Share PriceNT$141.00
52 Week HighNT$162.50
52 Week LowNT$71.04
Beta0
1 Month Change0.36%
3 Month Change4.44%
1 Year Change90.09%
3 Year Changen/a
5 Year Changen/a
Change since IPO87.67%

Recent News & Updates

Recent updates

Shareholder Returns

6955TW BiotechsTW Market
7D-0.4%-3.5%-1.6%
1Y90.1%1.1%28.6%

Return vs Industry: 6955 exceeded the TW Biotechs industry which returned 1.1% over the past year.

Return vs Market: 6955 exceeded the TW Market which returned 28.6% over the past year.

Price Volatility

Is 6955's price volatile compared to industry and market?
6955 volatility
6955 Average Weekly Movement3.7%
Biotechs Industry Average Movement4.2%
Market Average Movement4.5%
10% most volatile stocks in TW Market7.9%
10% least volatile stocks in TW Market2.0%

Stable Share Price: 6955 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 6955's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2015n/an/abonraybio.com

Bonraybio Co., Ltd., a development stage company, manufactures medical instruments and solutions for the male infertility market. The company provides LensHooke X12 PRO semen analysis systems; and LensHooke X1 PRO semen quality analyzers. It also offers consumables, such as CS3 semen test slides; CA0/CA1 sperm separation solutions; and CS1 semen test cassettes.

Bonraybio Co., Ltd. Fundamentals Summary

How do Bonraybio's earnings and revenue compare to its market cap?
6955 fundamental statistics
Market capNT$2.77b
Earnings (TTM)NT$0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6955 income statement (TTM)
RevenueNT$0
Cost of RevenueNT$0
Gross ProfitNT$0
Other ExpensesNT$0
EarningsNT$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did 6955 perform over the long term?

See historical performance and comparison

Dividends

0.1%

Current Dividend Yield

n/a

Payout Ratio